Skip to main content
. 2012 Feb 12;1(1):23–30. doi: 10.5501/wjv.v1.i1.23

Table 4.

Alternative PRRS vaccines

Encoded ORF/GP Immunogenicity
Protection
Ref.
Antibody CMI Homologous Heterologous
DNA vaccine ORF1-7 + + + ND [45,46]
Subunit vaccine GP5 Poor Poor - ND [47,48]
Synthetic peptide vaccine GP5 - - ND - [13]
Adenovirus vector vaccine GP3, 4, 5 + + ND ND [49-51]
PRV vector vaccine GP5, M + + + ND [52,53]
Poxvirus vector vaccine GP3, 5, M + + + ND [54,55]
TGEV vector vaccine GP5, M + ND + ND [56]
Alphavirus-derived replicon GP5, M + + + + [57]
Bacterial vector vaccine GP5, M + - + ND [58]
Insect cell-derived vaccine ORF3, 5, 7 + ND + ND [59]
Plant-derived vaccine GP5 + + ND ND [60,61]
Gene-deleted MLV (deleted15-mer nsp2 epitope) + ND ND ND [65]

+: Success; -: Failure; ND: Not determined.